AI
A few weeks ago I was at a conference where Ali Parsa, founder and CEO of Babylon Health, was the keynote speaker. It was a bold choice because nothing in the modern digital healthcare world seems to polarise opinion quite like Babylon, sending shivers of anxiety or excitement through their detractors and supporters.
Alexander Börve’s company FirstDerm offers online consultations with board-certified dermatologists and a free product that uses AI to give users ideas about what their skin condition might be.
The Department of Veterans Affairs and IBM Watson Health have announced a one-year extension to an ongoing public-private partnership applying the AI company’s technology to genomic data for cancer therapy.
Healthcare AI company Viz.
Experts predict that AI supported surgery will become ‘common practice’ in the next five years as a London start-up deploys an Artificial Intelligence Platform set to act as a ‘navigational system’ for healthcare professionals.
San Francisco-based predictive health company Potrero Medical has closed $26.
In a recent review, an independent group of panelists raised questions about UK-based AI company DeepMind’s business model, relationship with parent company Alphabet, and potential to monopolize its industry.
Last week the American Medical Association outlined a new set of recommendations on augmented intelligence, a type of technology that aims to extend, but not replace, a human medical expert’s insight and decision-making capabilities.
The new Rosalind Franklin Institute is investing £6m in ground-breaking initiatives that will disrupt the drug development process.